Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer

Figure 2 Effects of microwave ablation treatment on the serum alpha-fetoprotein levels in patients with primary liver cancer. The serum alpha-fetoprotein (AFP) levels were examined in the primary liver cancer patients before microwave ablation (MWA) treatment and at different time points after the treatment. The average serum AFP level was 110.4 mg/L before MWA treatment (pre-MWA), decreased sharply to 37.61 mg/L at 1 wk after MWA treatment, continued to decrease, returned to the normal range at 12 wk after MWA, and remained stable thereafter during follow-up in those cases without recurrence. For the recurrent cases with primary liver cancer, however, the serum AFP levels started to increase at 12 wk following the MWA treatment. AFP: Alpha-fetoprotein.